Literature DB >> 13560762

The effect of hypophysectomy in advanced carcinoma of the breast.

D N BARON, K J GURLING, E R SMITH.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/surgery; HYPOPHYSECTOMY

Mesh:

Year:  1958        PMID: 13560762     DOI: 10.1002/bjs.18004519407

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  10 in total

1.  Sheehans syndrome in association with diabetes insipidus.

Authors:  A GOTH
Journal:  Br Med J       Date:  1963-01-26

2.  The effect of hormone deprivation upon breast cancer.

Authors:  J HADFIELD
Journal:  Ann R Coll Surg Engl       Date:  1959-07       Impact factor: 1.891

3.  Factors influencing response to hypophysectomy for advanced cancer of breast.

Authors:  A MCCALISTER; R B WELBOURN; G J EDELSTYN; A R LYONS; A R TAYLOR; C A GLEADHILL; D S GORDON; J O COLE
Journal:  Br Med J       Date:  1961-03-04

4.  [Change in the hypophysis after radiogold implantation].

Authors:  H MATHEIS; A DOLLMANN
Journal:  Dtsch Z Nervenheilkd       Date:  1960

5.  The pituitary and adrenal cortex in general medicine.

Authors:  J D NABARRO
Journal:  Br Med J       Date:  1960-08-27

6.  Further Experiences with Hypophysectomy in Advanced Breast Cancer.

Authors:  E Boesen; E J Smith; D N Baron
Journal:  Br Med J       Date:  1961-09-23

7.  [Regulation of tumor growth by adenosine-3',5'-monophosphate].

Authors:  P Chandra; D Gericke
Journal:  Naturwissenschaften       Date:  1972-05

Review 8.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

9.  Treatment of advanced breast cancer by trans-sphenoidal hypophysectomy.

Authors:  B P Harrold; J E Cates; J A James
Journal:  Br J Cancer       Date:  1968-03       Impact factor: 7.640

10.  Plasma beta-glucuronidase levels in breast cancer.

Authors:  B L WHITAKER
Journal:  Br J Cancer       Date:  1960-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.